Effect of Drinking Fermented Milk on Immune Response

NCT ID: NCT02909842

Last Updated: 2017-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-01

Study Completion Date

2017-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This blinded randomized controlled trial aims to investigate the effect of drinking fermented milk containing Lactobacillus paracasei (IMULUS) on immune response against influenza.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is conducted in healthy volunteer using product approved by Thai FDA. This blinded randomized controlled trial compare immune response against influenza H1N1, H3N2 and Phu-B between study group and control group. The study group receives influenza vaccine and drinking fermented milk containing Lactobacillus paracasei (IMULUS), while the control group receives influenza vaccine and placebo acidified milk. The trial lasts for 8 weeks and include four time points of data collection (0, 2, 6, 8 weeks). Subjects, outcome assessor and investigators are blinded throughout the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

Seasonal Influenza Vaccine (H1N1, H3N2, PhuB) and 100 ml bottle of yoghurt drink, unlabelled drinking fermented milk containing probiotic, Lactobacillus paracasei (IMULUS)

Group Type EXPERIMENTAL

Drinking fermented milk

Intervention Type DIETARY_SUPPLEMENT

Drinking fermented milk containing Lactobacillus paracasei (IMULUS)

Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)

Intervention Type BIOLOGICAL

Intramuscular injection of a single shot of influenza vaccine

control group

Seasonal Influenza Vaccine (H1N1, H3N2, PhuB) and 100 ml bottle of placebo, unlabelled acidified milk with similar physical and sensory appearance to the experimental one

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DIETARY_SUPPLEMENT

Acidified placebo milk with similar physical characteristics to the yoghurt drink

Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)

Intervention Type BIOLOGICAL

Intramuscular injection of a single shot of influenza vaccine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Drinking fermented milk

Drinking fermented milk containing Lactobacillus paracasei (IMULUS)

Intervention Type DIETARY_SUPPLEMENT

placebo

Acidified placebo milk with similar physical characteristics to the yoghurt drink

Intervention Type DIETARY_SUPPLEMENT

Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)

Intramuscular injection of a single shot of influenza vaccine

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 45 years old
* healthy and having normal vital signs
* no history of uncontrolled systemic or autoimmune diseases
* no signs or symptoms of respiratory infection
* normal blood chemistry including complete blood count (CBC), liver and kidney function, lipid profile and fasting blood sugar
* no history of influenza vaccine during the past 6 months
* able to continuously take the intervention daily for 6 weeks
* able to refrain from other probiotic products such as drinking fermented milk or yoghurt since the beginning till the end of data collection
* accepted to receive influenza vaccine shot
* able to refrain from receiving other vaccine during the trial
* able to refrain from traveling to endemic area of influenza
* able to communicate in Thai and sign their written inform consent

Exclusion Criteria

* under pregnancy or expected to be pregnant
* lactose or milk protein intolerances
* daily intake of probiotic product for one month prior to recruitment
* chronic alcoholism
* GI disturbance e.g. stomachache, frequent diarrhea or constipation
* history of GI surgery
* ongoing treatment with antibiotic or other immune affecting drugs e.g. glucocorticoids, chemotherapy, antibodies, ciclosporin, hormone and opioids
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dunyaporn Trachootham

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dunyaporn Trachootham, DDS, PhD

Role: PRINCIPAL_INVESTIGATOR

Mahidol University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MU-CIRB 2015/145.2509

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intranasal LAIV Mucosal Immunity Examination
NCT07093281 NOT_YET_RECRUITING PHASE4